These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11760835)

  • 1. Conditional ablation of the osteoblast lineage in Col2.3deltatk transgenic mice.
    Visnjic D; Kalajzic I; Gronowicz G; Aguila HL; Clark SH; Lichtler AC; Rowe DW
    J Bone Miner Res; 2001 Dec; 16(12):2222-31. PubMed ID: 11760835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 3.6 kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells.
    Boban I; Jacquin C; Prior K; Barisic-Dujmovic T; Maye P; Clark SH; Aguila HL
    Bone; 2006 Dec; 39(6):1302-12. PubMed ID: 16938497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parabiosis model does not show presence of circulating osteoprogenitor cells.
    Boban I; Barisic-Dujmovic T; Clark SH
    Genesis; 2010 Mar; 48(3):171-82. PubMed ID: 20127800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures.
    Malaval L; Modrowski D; Gupta AK; Aubin JE
    J Cell Physiol; 1994 Mar; 158(3):555-72. PubMed ID: 8126078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Col1a1-driven transgenic markers of osteoblast lineage progression.
    Dacic S; Kalajzic I; Visnjic D; Lichtler AC; Rowe DW
    J Bone Miner Res; 2001 Jul; 16(7):1228-36. PubMed ID: 11450698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage.
    Kalajzic I; Kalajzic Z; Kaliterna M; Gronowicz G; Clark SH; Lichtler AC; Rowe D
    J Bone Miner Res; 2002 Jan; 17(1):15-25. PubMed ID: 11771662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.
    Chipoy C; Berreur M; Couillaud S; Pradal G; Vallette F; Colombeix C; Rédini F; Heymann D; Blanchard F
    J Bone Miner Res; 2004 Nov; 19(11):1850-61. PubMed ID: 15476586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures.
    Leboy PS; Beresford JN; Devlin C; Owen ME
    J Cell Physiol; 1991 Mar; 146(3):370-8. PubMed ID: 2022691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency.
    Visnjic D; Kalajzic Z; Rowe DW; Katavic V; Lorenzo J; Aguila HL
    Blood; 2004 May; 103(9):3258-64. PubMed ID: 14726388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling.
    Sher LB; Harrison JR; Adams DJ; Kream BE
    Calcif Tissue Int; 2006 Aug; 79(2):118-25. PubMed ID: 16927049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
    Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
    Dacquin R; Starbuck M; Schinke T; Karsenty G
    Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualizing levels of osteoblast differentiation by a two-color promoter-GFP strategy: Type I collagen-GFPcyan and osteocalcin-GFPtpz.
    Bilic-Curcic I; Kronenberg M; Jiang X; Bellizzi J; Mina M; Marijanovic I; Gardiner EM; Rowe DW
    Genesis; 2005 Oct; 43(2):87-98. PubMed ID: 16149065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of osteoblast precursor cells from human bone marrow.
    Rickard DJ; Kassem M; Hefferan TE; Sarkar G; Spelsberg TC; Riggs BL
    J Bone Miner Res; 1996 Mar; 11(3):312-24. PubMed ID: 8852942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting megakaryocytopoiesis in vivo with toxigenes.
    Marguerie G; Roullot V; Tronik-Le Roux D
    Stem Cells; 1996; 14 Suppl 1():200-5. PubMed ID: 11012222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
    Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
    J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.